OpenAI announced Thursday that it has entered into an agreement to acquire Astral, the company behind popular open source Python development tools such as uv, Ruff, and ty, and integrate the company ...

Metabolites from python blood have the potential to lead to the creation of weight-loss medications similar to Ozempic, according to new research. At first, scientists at Stanford University, Baylor ...

OpenAI, the leading artificial intelligence platform, has aimed to built a strong platform against Anthropic. The ChatGPT owner said on Thursday, March 20, 2026, it will acquire Python ...

March 19 (Reuters) - OpenAI said on Thursday it will acquire Python toolmaker Astral, as the ChatGPT owner looks to ...

New research suggests python blood could hold the key to a new weight-loss drug, as the snake metabolite suppresses appetites in mice. It is the ...

With some help from his family, python contractor Carl Jackson caught the second-heaviest Burmese python ever captured in the wild in Florida.

A reticulated python has already completed its hunt of this small deer and is in the process of constricting its prey.

Discover how a compound from Burmese python blood helped mice curb their appetite and lose weight in a groundbreaking study.

OpenAI has acquired Astral, a startup whose essential Python development tools are used by millions. This strategic move aims ...

Researchers have found a metabolite in Burmese pythons that suppresses appetite in mice without some of GLP-1's side effects. And humans make it, too.